Dr. Aaron Ellenbogen, DO, MPH
Claim this profileQuest Research Institute
Studies Parkinson's Disease
Studies Alzheimer's Disease
19 reported clinical trials
16 drugs studied
Affiliated Hospitals
Clinical Trials Aaron Ellenbogen, DO, MPH is currently running
Donanemab
for Alzheimer's Disease
This trial is testing donanemab, a medication aimed at helping people with Alzheimer's Disease by removing harmful protein clumps from their brains. Donanemab has shown promise in reducing these harmful proteins in Alzheimer's disease.
Recruiting1 award Phase 34 criteria
FNP-223
for Progressive Supranuclear Palsy
PROSPER trial is a trial to assess the efficacy of FNP-223 in slowing disease progression in participants with PSP as measured by the PSP Rating Scale (PSPRS) over 52 weeks and to assess the safety and tolerability of FNP-223 for 52 weeks in participants with PSP.
Recruiting0 awards Phase 24 criteria
More about Aaron Ellenbogen, DO, MPH
Clinical Trial Related3 years of experience running clinical trials · Led 19 trials as a Principal Investigator · 8 Active Clinical TrialsTreatments Aaron Ellenbogen, DO, MPH has experience with
- Placebo
- Donanemab
- ABP-450
- Tavapadon
- Buntanetap
- AAV2-GDNF Gene Therapy
Breakdown of trials Aaron Ellenbogen, DO, MPH has run
Parkinson's Disease
Alzheimer's Disease
Atrophy
Multiple System Atrophy
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Aaron Ellenbogen, DO, MPH specialize in?
Aaron Ellenbogen, DO, MPH focuses on Parkinson's Disease and Alzheimer's Disease. In particular, much of their work with Parkinson's Disease has involved treating patients, or patients who are undergoing treatment.
Is Aaron Ellenbogen, DO, MPH currently recruiting for clinical trials?
Yes, Aaron Ellenbogen, DO, MPH is currently recruiting for 8 clinical trials in Farmington Hills Michigan. If you're interested in participating, you should apply.
Are there any treatments that Aaron Ellenbogen, DO, MPH has studied deeply?
Yes, Aaron Ellenbogen, DO, MPH has studied treatments such as Placebo, Donanemab, ABP-450.
What is the best way to schedule an appointment with Aaron Ellenbogen, DO, MPH?
Apply for one of the trials that Aaron Ellenbogen, DO, MPH is conducting.
What is the office address of Aaron Ellenbogen, DO, MPH?
The office of Aaron Ellenbogen, DO, MPH is located at: Quest Research Institute, Farmington Hills, Michigan 48334 United States. This is the address for their practice at the Quest Research Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.